Incyte

IPO

Solve On.

Public · Wilmington, United States · Founded 1991

Founded
1991
Business Model
B2B
Website
incyte.com
Type
Public

About

Incyte is a global biopharmaceutical company on a mission to Solve On, with three core therapeutic franchises in Hematology, Oncology, and Inflammation and Autoimmunity. Founded in 1991 and headquartered in Wilmington, Delaware, Incyte has grown from a small team of scientists into a global organization with a robust portfolio of approved treatments and a broad clinical pipeline. The company discovers, develops, and commercializes novel medicines to address serious unmet medical needs, with a particular focus on dermatology within the inflammation and autoimmunity space. Incyte operates globally with offices and operations across North America, Europe, and Asia.

Summary

Incyte is a Biotech company based in Wilmington, United States, founded in 1991.

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Exit History

IPONov 1993
$15.0M

Acquisitions

Similar Companies

Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020
BridgeBioIPO

BridgeBio develops treatments for genetic conditions through autonomous condition-focused teams s...

San Francisco Bay Area, United States201–500Biotech, Healthcare
Growth EquityTotal funding$2.7BJul 2026

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Incyte on Indexed.vc
<a href="https://indexed.vc/companies/incyte"><img src="https://indexed.vc/api/badge/company/incyte" alt="Incyte on Indexed.vc" width="260" height="76" /></a>